Development and Evaluation of Ultrasound Image Learning Pipelines for MASLD Risk Stratification
DGX agentarXiv:2609.04390v1 Announce Type: cross Abstract: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 30% of the general population. Ultrasound-based imaging, includ